Palbociclib shows improved PFS but not improved OS for ER+ HER2- mBC patients

Lack of access to new cancer medicines in LMICs

Comment: LUMINA results show that women with low levels of the Ki67 biomarker can avoid outcomes related to radiotherapy

Biomarker guidance allows patients 55 or older with low-grade luminal A-type breast cancer to avoid radiation therapy

Comment: Biomarker guidance allows patients 55 or older with low-grade luminal A-type breast cancer to avoid radiation therapy

Luminal A-type breast cancer patients with low levels of the Ki67 biomarker can avoid outcomes related to radiotherapy

ASCO 2022: Highlights and analysis

The global impact of the FDA's changing approval standards

Evidence-based oncology for trainees from LMICs

Cancer drug policy and access in LMICs

Choosing Trials Wisely: What type of clinical trials should be a priority for LMICs?

ESMO 2021 Roundup